Cargando…
Surrogate Adiposity Markers and Mortality
IMPORTANCE: Body mass index (BMI) is an easily obtained adiposity surrogate. However, there is variability in body composition and adipose tissue distribution between individuals with the same BMI, and there is controversy regarding the BMI associated with the lowest mortality risk. OBJECTIVE: To ev...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512100/ https://www.ncbi.nlm.nih.gov/pubmed/37728925 http://dx.doi.org/10.1001/jamanetworkopen.2023.34836 |
_version_ | 1785108289025998848 |
---|---|
author | Khan, Irfan Chong, Michael Le, Ann Mohammadi-Shemirani, Pedrum Morton, Robert Brinza, Christina Kiflen, Michel Narula, Sukrit Akhabir, Loubna Mao, Shihong Morrison, Katherine Pigeyre, Marie Paré, Guillaume |
author_facet | Khan, Irfan Chong, Michael Le, Ann Mohammadi-Shemirani, Pedrum Morton, Robert Brinza, Christina Kiflen, Michel Narula, Sukrit Akhabir, Loubna Mao, Shihong Morrison, Katherine Pigeyre, Marie Paré, Guillaume |
author_sort | Khan, Irfan |
collection | PubMed |
description | IMPORTANCE: Body mass index (BMI) is an easily obtained adiposity surrogate. However, there is variability in body composition and adipose tissue distribution between individuals with the same BMI, and there is controversy regarding the BMI associated with the lowest mortality risk. OBJECTIVE: To evaluate which of BMI, fat mass index (FMI), and waist-to-hip (WHR) has the strongest and most consistent association with mortality. DESIGN, SETTING, AND PARTICIPANT: This cohort study used incident deaths from the UK Biobank (UKB; 2006-2022), which includes data from 22 clinical assessment centers across the United Kingdom. UKB British participants of British White ancestry (N = 387 672) were partitioned into a discovery cohort (n = 337 078) and validation cohort (n = 50 594), with the latter consisting of 25 297 deaths and 25 297 controls. The discovery cohort was used to derive genetically determined adiposity measures while the validation cohort was used for analyses. Exposure-outcome associations were analyzed through observational and mendelian randomization (MR) analyses. EXPOSURES: BMI, FMI, and WHR. MAIN OUTCOMES AND MEASURES: All-cause and cause-specific (cancer, cardiovascular disease [CVD], respiratory disease, or other causes) mortality. RESULTS: There were 387 672 and 50 594 participants in our observational (mean [SD] age, 56.9 [8.0] years; 177 340 [45.9%] male, 210 332 [54.2%], female), and MR (mean [SD] age, 61.6 [6.2] years; 30 031 [59.3%] male, 20 563 [40.6%], female) analyses, respectively. Associations between measured BMI and FMI with all-cause mortality were J-shaped, whereas the association of WHR with all-cause mortality was linear using the hazard ratio (HR) scale (HR per SD increase of WHR, 1.41 [95% CI, 1.38-1.43]). Genetically determined WHR had a stronger association with all-cause mortality than BMI (odds ratio [OR] per SD increase of WHR, 1.51 [95% CI, 1.32-1.72]; OR per SD increase of BMI, 1.29 [95% CI, 1.20-1.38]; P for heterogeneity = .02). This association was stronger in male than female participants (OR, 1.89 [95% CI, 1.54-2.32]; P for heterogeneity = .01). Unlike BMI or FMI, the genetically determined WHR–all-cause mortality association was consistent irrespective of observed BMI. CONCLUSIONS AND RELEVANCE: In this cohort study, WHR had the strongest and most consistent association with mortality irrespective of BMI. Clinical recommendations should consider focusing on adiposity distribution compared with mass. |
format | Online Article Text |
id | pubmed-10512100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-105121002023-09-22 Surrogate Adiposity Markers and Mortality Khan, Irfan Chong, Michael Le, Ann Mohammadi-Shemirani, Pedrum Morton, Robert Brinza, Christina Kiflen, Michel Narula, Sukrit Akhabir, Loubna Mao, Shihong Morrison, Katherine Pigeyre, Marie Paré, Guillaume JAMA Netw Open Original Investigation IMPORTANCE: Body mass index (BMI) is an easily obtained adiposity surrogate. However, there is variability in body composition and adipose tissue distribution between individuals with the same BMI, and there is controversy regarding the BMI associated with the lowest mortality risk. OBJECTIVE: To evaluate which of BMI, fat mass index (FMI), and waist-to-hip (WHR) has the strongest and most consistent association with mortality. DESIGN, SETTING, AND PARTICIPANT: This cohort study used incident deaths from the UK Biobank (UKB; 2006-2022), which includes data from 22 clinical assessment centers across the United Kingdom. UKB British participants of British White ancestry (N = 387 672) were partitioned into a discovery cohort (n = 337 078) and validation cohort (n = 50 594), with the latter consisting of 25 297 deaths and 25 297 controls. The discovery cohort was used to derive genetically determined adiposity measures while the validation cohort was used for analyses. Exposure-outcome associations were analyzed through observational and mendelian randomization (MR) analyses. EXPOSURES: BMI, FMI, and WHR. MAIN OUTCOMES AND MEASURES: All-cause and cause-specific (cancer, cardiovascular disease [CVD], respiratory disease, or other causes) mortality. RESULTS: There were 387 672 and 50 594 participants in our observational (mean [SD] age, 56.9 [8.0] years; 177 340 [45.9%] male, 210 332 [54.2%], female), and MR (mean [SD] age, 61.6 [6.2] years; 30 031 [59.3%] male, 20 563 [40.6%], female) analyses, respectively. Associations between measured BMI and FMI with all-cause mortality were J-shaped, whereas the association of WHR with all-cause mortality was linear using the hazard ratio (HR) scale (HR per SD increase of WHR, 1.41 [95% CI, 1.38-1.43]). Genetically determined WHR had a stronger association with all-cause mortality than BMI (odds ratio [OR] per SD increase of WHR, 1.51 [95% CI, 1.32-1.72]; OR per SD increase of BMI, 1.29 [95% CI, 1.20-1.38]; P for heterogeneity = .02). This association was stronger in male than female participants (OR, 1.89 [95% CI, 1.54-2.32]; P for heterogeneity = .01). Unlike BMI or FMI, the genetically determined WHR–all-cause mortality association was consistent irrespective of observed BMI. CONCLUSIONS AND RELEVANCE: In this cohort study, WHR had the strongest and most consistent association with mortality irrespective of BMI. Clinical recommendations should consider focusing on adiposity distribution compared with mass. American Medical Association 2023-09-20 /pmc/articles/PMC10512100/ /pubmed/37728925 http://dx.doi.org/10.1001/jamanetworkopen.2023.34836 Text en Copyright 2023 Khan I et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Khan, Irfan Chong, Michael Le, Ann Mohammadi-Shemirani, Pedrum Morton, Robert Brinza, Christina Kiflen, Michel Narula, Sukrit Akhabir, Loubna Mao, Shihong Morrison, Katherine Pigeyre, Marie Paré, Guillaume Surrogate Adiposity Markers and Mortality |
title | Surrogate Adiposity Markers and Mortality |
title_full | Surrogate Adiposity Markers and Mortality |
title_fullStr | Surrogate Adiposity Markers and Mortality |
title_full_unstemmed | Surrogate Adiposity Markers and Mortality |
title_short | Surrogate Adiposity Markers and Mortality |
title_sort | surrogate adiposity markers and mortality |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512100/ https://www.ncbi.nlm.nih.gov/pubmed/37728925 http://dx.doi.org/10.1001/jamanetworkopen.2023.34836 |
work_keys_str_mv | AT khanirfan surrogateadipositymarkersandmortality AT chongmichael surrogateadipositymarkersandmortality AT leann surrogateadipositymarkersandmortality AT mohammadishemiranipedrum surrogateadipositymarkersandmortality AT mortonrobert surrogateadipositymarkersandmortality AT brinzachristina surrogateadipositymarkersandmortality AT kiflenmichel surrogateadipositymarkersandmortality AT narulasukrit surrogateadipositymarkersandmortality AT akhabirloubna surrogateadipositymarkersandmortality AT maoshihong surrogateadipositymarkersandmortality AT morrisonkatherine surrogateadipositymarkersandmortality AT pigeyremarie surrogateadipositymarkersandmortality AT pareguillaume surrogateadipositymarkersandmortality |